Meeting
2013 ASCO Annual Meeting
Are three drugs better than two and does docetaxel trump paclitaxel in induction therapy for locally advanced oral cavity cancers?
Authors
Vanita Noronha
Tata Memorial Hospital, Mumbai, India
Vanita Noronha , Vijay Patil , Amit Joshi , S Juvekar , Bharatsinha Baburao Bhosale , Bhavesh Poladia , Sushmita Rath , Pankaj Chaturvedi , D. Chaukar , P. S. Pai , A. K. Dcruz , Kumar Prabhash
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Head and Neck Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 6085)
DOI
10.1200/jco.2013.31.15_suppl.6085
Abstract #
6085
Poster Bd #
16A
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Randomized phase II study with or without induction chemotherapy combined with accelerated high dose radiotherapy and cetuximab in locally advanced unresectable HPV positive squamous cell carcinoma of the head and neck.
First Author: Signe Friesland
Poster
2019 Genitourinary Cancers Symposium
Cross-trial comparison of taxane versus non-taxane combination chemotherapy regimens for advanced penile cancer (APC): A systematic review.
First Author: Esmail Mutahar Al-Ezzi
Poster
2014 ASCO Annual Meeting
Randomized phase II trial of weekly paclitaxel, carboplatin, cetuximab (PCC) versus cetuximab, docetaxel, cisplatin, and fluorouracil (C-TPF) in previously untreated patients with locally advanced head and neck squamous cell carcinoma.
First Author: Erminia Massarelli
Poster
2013 ASCO Annual Meeting
Induction chemotherapy (CT) with docetaxel, cisplatin, and fluorouracil (TPF) followed by concomitant cisplatin plus radiotherapy in locally advanced nasopharyngeal cancer (NPC): Results after 06 years.
First Author: Esma Kerboua